{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T01:13:46Z","timestamp":1725671626184},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDS"],"published-print":{"date-parts":[[2007,9,1]]},"DOI":"10.2174\/157488607781668846","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T20:44:03Z","timestamp":1208465043000},"page":"227-231","source":"Crossref","is-referenced-by-count":6,"title":["Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis"],"prefix":"10.2174","volume":"2","author":[{"given":"Jean-Louis","family":"Vincent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/59759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:24:28Z","timestamp":1448270668000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1574-8863&volume=2&issue=3&spage=227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/157488607781668846","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}